Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2

Status

Recruiting 3Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Head & Neck 6Endocrine 3Thoracic 2Tumor-Agnostic 1Other 1Gastrointestinal 1Breast 1

Conditions

Thyroid Neoplasms 5Thyroid Cancer, Papillary 2Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Carcinoma, Medullary 1Advanced Thyroid Cancer Patients Who Received Target Therapy 1Adenocarcinoma, Follicular 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × selpercatinib × Head & Neck × Clear all
NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
30 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07543887 2026-04-22

EECRTKI

University of Pisa

Completed
15 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Recruiting
120 enrolled
Head & Neck

Thyroid Neoplasms

NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

NCT07010393 2025-06-08

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Fujian Medical University

Phase 4 Not yet recruiting
335 enrolled
Head & Neck

Thyroid Neoplasms

NCT05668962 2024-12-12

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Massachusetts General Hospital

Phase 2 Recruiting
30 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡